Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 4/20 | 0.70 |
| ▸ | CMA1 | P23946 | 1/20 | 0.70 |
| ▸ | F7 | P08709 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | F3 | P13726 | 1/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.47 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.45 |
| ▸ | PIP4K2A | P48426 | 1/20 | 0.44 |
| ▸ | PIP4K2B | P78356 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.44 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4486564 | 0.84 | AHR (0.70) | AHRCMA1F7LTA4HF3 | |
| SCHEMBL5664020 | 0.83 | AHR (0.63) | AHRCMA1F7LTA4HF3 | |
| SCHEMBL29990254 | 0.83 | AHR (1.00) | AHRCMA1F7LTA4HF3 | |
| SCHEMBL75475 | 0.83 | AHR (1.00) | AHRCMA1F7LTA4HF3 | |
| SCHEMBL443799 | 0.82 | NPC1 (0.71) | AHRCMA1NPC1TYRCHRNB4 | |
| SCHEMBL30253604 | 0.82 | NPC1 (0.71) | AHRCMA1NPC1TYRCHRNB4 | |
| Methane SCHEMBL27929624 | 0.81 | AHR (0.95) | AHRCMA1F7LTA4HF3 | |
| SCHEMBL27701627 | 0.81 | AHR (0.95) | AHRCMA1F7LTA4HF3 | |
| Biphenyl SCHEMBL27962709 | 0.81 | AHR (0.78) | AHRCMA1F7LTA4HF3 | |
| SCHEMBL13115618 | 0.80 | BRD4 (0.53) | AHRCMA1ESR1NPC1TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109503598-A | The method of level-one amine guiding building 6- (4- chlorphenyl) indoles simultaneously [1,2-a] quinoxaline | 桂林理工大学 | 2019-03-22 | — | — | CN | disclosed |
| CN-109503598-A | The method of level-one amine guiding building 6- (4- chlorphenyl) indoles simultaneously [1,2-a] quinoxaline | 桂林理工大学 | 2019-03-22 | — | — | CN | disclosed |
| CN-109503598-A | The method of level-one amine guiding building 6- (4- chlorphenyl) indoles simultaneously [1,2-a] quinoxaline | 桂林理工大学 | 2019-03-22 | — | — | CN | disclosed |
| US-20030203959-A1 | Novel modulators of potassium channels | 4SC AG (DE) | 2003-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203959-A1 | Novel modulators of potassium channels | HCN3, KCNN3, KCNN1 | AHR 379/4885CMA1 1511/4885F7 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.